Daily News Podcast

Novel formulation for childhood ADHD

Publish date: November 20, 2018

 

A novel formulation of methylphenidate could provide morning relief to pediatric patients with attention-deficit hyperactivity disorder. Also today, CARE MD protocol could help treat somatic disorders, children with poor cardiorespiratory fitness have a higher risk of type 2 diabetes, and ganglion stimulation boosts cerebral blood flow and improves stroke outcomes.
Amazon Alexa
Apple Podcasts
Google Podcasts

Recommended Reading

Samuel Shem: Part II
MDedge Psychiatry
'Real food' called key to healthful eating; Peer mentors seek to prevent suicides
MDedge Psychiatry
Trump rule and ACA contraception
MDedge Psychiatry
DBT can help traumatized, suicidal youth manage emotions
MDedge Psychiatry
Heart failure and sacubiril/valsartan
MDedge Psychiatry
Vitamin D, fish out, and primary prevention
MDedge Psychiatry
Robin Cooper: Climate Change
MDedge Psychiatry
USPSTF: screen for ‘unhealthy’ alcohol use
MDedge Psychiatry
Obesity curbs decades of CVD progress
MDedge Psychiatry
Physical fitness guidelines from HHS
MDedge Psychiatry